Lethargic Depression Study

Clinical trial NCT00064467 · COMPLETED

Trial details

NCT number: NCT00064467
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Epilepsy Major Depressive Disorder (MDD)

Start date: 2003-06-01
Primary completion: 2005-05-01
Enrollment: 268

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.